SlideShare ist ein Scribd-Unternehmen logo
1 von 68
Downloaden Sie, um offline zu lesen
Risk,	
  Recognize,	
  Resolve:	
  Addic2on	
  
                 in	
  the	
  
          Pharmacy	
  Profession	
  	
  
              April	
  2	
  –	
  4,	
  2013	
  
            Omni	
  Orlando	
  Resort	
  	
  
             at	
  ChampionsGate	
  
Learning	
  Objec2ves	
  

•  1.	
  Iden=fy	
  risk	
  factors	
  for	
  pharmacy	
  professionals	
  that	
  
   may	
  influence	
  the	
  development	
  of	
  the	
  disease	
  of	
  
   addic=on.	
  
•  2.	
  Iden=fy	
  the	
  signs	
  and	
  symptoms	
  of	
  the	
  disease	
  of	
  
   addic=on.	
  
•  3.	
  Describe	
  the	
  resources	
  available	
  to	
  pharmacy	
  
   professionals	
  when	
  a	
  colleague	
  may	
  need	
  assistance	
  
   with	
  addic=on	
  or	
  substance	
  abuse	
  issues.	
  
•  4.	
  Describe	
  the	
  structure	
  of	
  accountability	
  added	
  to	
  the	
  
   recovery	
  person	
  by	
  monitoring	
  with	
  a	
  Pharmacist	
  
   Recovery	
  Network.	
  
Disclosure	
  Statement	
  
Brian	
  Fingerson	
  has	
  no	
  financial	
  rela=onships	
  
with	
  proprietary	
  en==es	
  that	
  produce	
  health	
  
care	
  goods	
  and	
  services.	
  
Brian	
  Fingerson,	
  RPh	
  
•  President,	
  KYPRN	
  –	
  Kentucky	
  Professionals	
  Recovery	
  
   Network	
  since	
  1986	
  
•  Clients/professions	
  include:	
  Accountants,	
  Pharmacy,	
  
   Den=stry,	
  Physical	
  Therapy,	
  Veterinary	
  Medicine,	
  
   Respiratory	
  Care,	
  Optometry,	
  Chiroprac=c,	
  Social	
  
   Work	
  
•  Work	
  with	
  these	
  professionals	
  through	
  their	
  licensing	
  
   Boards	
  
What	
  do	
  you	
  know?	
  
Self-­‐Assessment	
  Ques2ons	
  T	
  or	
  F	
  
•  In	
  a	
  diagnosis	
  of	
  addic=on	
  using	
  DSM	
  IV	
  criteria,	
  one	
  must	
  exhibit	
  any	
  
   two	
  out	
  of	
  seven	
  of	
  the	
  criteria	
  within	
  the	
  past	
  six	
  months.	
  	
  
•  Gene=cs	
  is	
  the	
  sole	
  determining	
  factor	
  as	
  to	
  whether	
  someone	
  becomes	
  
   addicted	
  to	
  a	
  substance	
  or	
  process.	
  
•  The	
  prognosis	
  for	
  someone	
  who	
  is	
  addicted	
  to	
  a	
  substance	
  includes	
  these	
  
   three:	
  1)	
  get	
  sober;	
  2)	
  get	
  locked	
  up;	
  or	
  3)	
  die.	
  
•  Alcoholism,	
  chemical	
  addic=on,	
  is	
  a	
  disease,	
  the	
  very	
  nature	
  of	
  which	
  
   renders	
  the	
  vic=m	
  incapable	
  of	
  recognizing	
  the	
  severity	
  of	
  the	
  symptoms,	
  
   the	
  progression	
  of	
  the	
  disease,	
  or	
  of	
  accep=ng	
  any	
  ordinary	
  offers	
  of	
  
   help.	
  
And	
  why	
  should	
  we	
  learn	
  about	
  addic2on	
  in	
  
                     pharmacy	
  professionals?	
  
Crit	
  Care	
  Med.	
  2007	
  Feb;35(2	
  Suppl):S106-­‐16	
  
   Baldisseri	
  MR.	
  

      Cri=cal	
  Care	
  Medicine,	
  University	
  of	
  Pidsburgh	
  School	
  
      of	
  Medicine,	
  Pidsburgh,	
  Pennsylvania,	
  USA.	
  	
  
      OBJECTIVE:	
  The	
  objec1ve	
  of	
  the	
  ar1cle	
  is	
  to	
  present	
  the	
  
      available	
  data	
  from	
  the	
  literature	
  on	
  substance	
  use	
  
      disorders	
  in	
  healthcare	
  professionals.	
  Prevalence,	
  risk	
  
      factors,	
  treatment	
  op1ons,	
  and	
  reentry	
  into	
  clinical	
  
      prac1ce	
  are	
  discussed.	
  
Crit	
  Care	
  Med.	
  2007	
  Feb;35(2	
  Suppl):S106-­‐16	
  
                                Baldisseri	
  MR.	
  
•  INTRODUCTION:	
  Impairment	
  of	
  a	
  healthcare	
  professional	
  is	
  
   the	
  inability	
  or	
  impending	
  inability	
  to	
  prac5ce	
  according	
  to	
  
   accepted	
  standards	
  as	
  a	
  result	
  of	
  substance	
  use,	
  abuse,	
  or	
  
   dependency	
  (addic5on).	
  The	
  term	
  substance	
  use	
  disorder	
  can	
  
   be	
  divided	
  into	
  substance	
  abuse	
  and	
  dependence	
  (addic1on).	
  
   Substance	
  abuse	
  results	
  in	
  adverse	
  social	
  and	
  professional	
  
   consequences.	
  Addic5on	
  manifests	
  as	
  physiologic	
  and	
  
   behavioral	
  symptoms	
  related	
  to	
  a	
  maladap1ve	
  paLern	
  of	
  
   substance	
  use.	
  
•  MAIN	
  RESULTS:	
  It	
  is	
  es1mated	
  that	
  approximately	
  10%	
  to	
  
   15%	
  of	
  all	
  healthcare	
  professionals	
  will	
  misuse	
  drugs	
  or	
  
   alcohol	
  alcohol	
  some	
  1me	
  during	
  their	
  career.	
  
Why	
  do	
  people	
  take	
  
drugs	
  “recrea2onally”	
  in	
  
    the	
  first	
  place?	
  
People	
  Take	
  Drugs	
  To:	
  

• Feel	
  good	
  (sensa2on	
  seeking)	
  
• Feel	
  be[er	
  (self-­‐medica2on)	
  
A	
  major	
  reason	
  people	
  take	
  	
  
a	
  psychoac2ve	
  drug	
  is	
  they	
  
               like	
  what	
  
      it	
  does	
  to	
  their	
  brains	
  
Prolonged drug use changes
the brain in fundamental and
     long-lasting ways
Reward Pathway
                 Frontal	
  Cortex	
  




                                  Wow!!!	
  

  Addiction
     is a                                Opiates
brain disease                            Alcohol
                                         Cocaine
                                         Amphetamines
                                         Marijuana
Young adults 	
  may	
   be less
              	
   	
   	
   	
   	
  
likely to develop serious alcohol
    and other drug problems
     if the age of first use is
  delayed beyond childhood or
            adolescence
AA	
  Grapevine	
  e-­‐poll	
  
  Ques2on:	
  At	
  what	
  age	
  did	
  
  you	
  have	
  your	
  first	
  drink?	
  	
  
   Total	
  Responded:	
  7947	
  	
  




 0-­‐11	
                                         2308	
  votes	
  (29.04	
  %)	
  

 12-­‐18	
                                        5110	
  votes	
  (64.3	
  %)	
  

 19-­‐26	
                                        420	
  votes	
  (5.29	
  %)	
  

 27-­‐40	
                                        52	
  votes	
  (0.65	
  %)	
  

 41	
  or	
  older	
                              57	
  votes	
  (0.72	
  %)	
  
Addic2on:	
  One	
  Defini2on	
  
•  A	
  primary,	
  chronic,	
  neurobiological	
  disease,	
  
   with	
  gene2c,	
  psychosocial,	
  and	
  
   environmental	
  factors	
  influencing	
  its	
  
   development	
  and	
  manifesta2ons.	
  	
  It	
  is	
  
   characterized	
  by	
  behaviors	
  that	
  include	
  one	
  
   or	
  more	
  of	
  the	
  following:	
  
Addic2on	
  behaviors:	
  
•  Impaired	
  control	
  
   over	
  drug	
  use	
  
•  Compulsive	
  use	
  
•  Con2nued	
  use	
  
   despite	
  harm	
  
•  Craving	
  
Fr	
  Vernon	
  Johnson’s	
  defini2on	
  of	
  addic2on	
  
•  “”Alcoholism,	
  chemical	
  addic2on,	
  is	
  a	
  
   disease,	
  the	
  very	
  nature	
  of	
  which	
  renders	
  the	
  
   vic2m	
  incapable	
  of	
  recognizing	
  the	
  severity	
  
   of	
  the	
  symptoms,	
  the	
  progression	
  of	
  the	
  
   disease,	
  or	
  of	
  accep2ng	
  any	
  ordinary	
  offers	
  of	
  
   help.”	
  
DSM	
  IV:	
  Diagnosis	
  of	
  Addic2on	
  
               (3	
  out	
  of	
  7	
  in	
  past	
  12	
  months)	
  
1.  Tolerance	
  
2.  Withdrawal	
  
Loss	
  of	
  Control:	
  
3.  Used	
  more	
  and	
  longer	
  than	
  planned	
  
4.  Unsuccessful	
  a[empts	
  to	
  quit	
  or	
  control	
  use	
  
5.  Excessive	
  2me	
  spent	
  obtaining,	
  using,	
  or	
  	
  	
  	
  
     recovering	
  from	
  use	
  
6.  Important	
  ac2vi2es	
  given	
  up	
  
7.  Con2nued	
  use	
  despite	
  adverse	
  consequences	
  
DSM-­‐V	
  
Risk	
  as	
  a	
  healthcare	
  professional?	
  
 Don’t	
  know	
  of	
  
  anyone	
  yet	
  whose	
  
  reason	
  for	
  
  becoming	
  a	
  
  pharmacist	
  was	
  
  drug	
  access.	
  	
  But…
  maybe	
  so?	
  
Risk	
  Factors	
  
•  General	
  Public	
  =	
  10%	
  

•  Pharmacists	
  and	
  some	
  other	
  
   health	
  care	
  professionals	
  =	
  HCP	
  =	
  
   12-­‐16%	
  
So…Why	
  an	
  increased	
  risk	
  factor?	
  
•    Access	
  to	
  drugs	
  
•    Stress	
  
•    Knowledge	
  
•    Family	
  history	
  =	
  1	
  
     parent	
  20-­‐25%	
  
     chance,	
  2	
  parents	
  
     30-­‐50%	
  
 And	
  how	
  can	
  this	
  be,	
  you	
  say?	
  
•  Dean	
  Dabney	
  in	
  
   JAPhA,	
  May/June	
  
   2001	
  
•  Vol.	
  41,	
  No.	
  3	
  	
  
•  Use	
  of	
  Mind	
  Altering	
  
   or	
  Poten2ally	
  
   Addic2ve	
  Prescrip2on	
  
   Drugs	
  (PAPD)	
  
Who	
  was	
  asked?	
  

•  It	
  was	
  a	
  random	
  sample	
  of	
  
   licensed,	
  prac2cing	
  pharmacists	
  
   who	
  were	
  members	
  of	
  APhA	
  in	
  
   the	
  fall	
  of	
  1996.	
  
  	
  And	
  what	
  did	
  the	
  study	
   	
  
                                	
  show?	
  
•  40%	
  indicated	
  using	
  PAPD	
  
   without	
  1st	
  obtaining	
  an	
  
   Rx	
  
•  20%	
  reported	
  5	
  or	
  more	
  
   life2me	
  episodes	
  
•  6%	
  reported	
  10	
  or	
  more	
  
   life2me	
  episodes	
  
•  6%	
  iden2fying	
  as	
  being	
  
   drug	
  abusers	
  
•  Drugs	
  obtained	
  by	
  
   stealing	
  drugs	
  from	
  
   employers	
  or	
  forging	
  Rx	
  
DENIAL – not just a river in Egypt*
                    Yes – it has been said before!



•  Don’t	
  
•  Even	
  
•  Know	
  
•  I	
  
•  Am	
  
•  Lying	
  
Denial	
  
                    from	
  Knots	
  by	
  R.D.	
  Lang	
  


•  There	
  must	
  be	
  something	
  the	
  
   ma[er	
  with	
  him	
  because	
  he	
  would	
  
   not	
  be	
  ac2ng	
  as	
  he	
  does	
  unless	
  
   there	
  was.	
  	
  Therefore	
  he	
  is	
  ac2ng	
  as	
  
   he	
  is	
  because	
  there	
  is	
  something	
  the	
  
   ma[er	
  with	
  him.	
  
Denial	
  con2nued:	
  
•  He	
  does	
  not	
  think	
  there	
  is	
  anything	
  the	
  
   ma[er	
  with	
  him	
  because	
  one	
  of	
  the	
  things	
  
   that	
  is	
  the	
  ma[er	
  with	
  him	
  is	
  that	
  he	
  does	
  
   not	
  think	
  that	
  there	
  is	
  anything	
  the	
  ma[er	
  
   with	
  him.	
  
•  Therefore	
  we	
  have	
  to	
  help	
  him	
  realize	
  that,	
  
   the	
  fact	
  that	
  he	
  does	
  not	
  think	
  there	
  is	
  
   anything	
  the	
  ma[er	
  with	
  him	
  is	
  one	
  of	
  the	
  
   things	
  that	
  is	
  the	
  ma[er	
  with	
  him.	
  
HCP	
  good	
  at	
  “cover	
  up”	
  and	
  if	
  
             confronted	
  will	
  deny	
  
•  Denial	
  is	
  not	
  just	
  a	
  river	
  in	
  Egypt	
  
•  Paranoia	
  and	
  irritability	
  
•  Depression	
  
•  Use	
  of	
  large	
  quan22es	
  of	
  alcohol	
  –	
  more	
  
   than	
  normal	
  or	
  more	
  than	
  others	
  
   present	
  
•  Blackouts	
  
Blackouts	
  
                 -­‐	
  Once	
  a	
  person	
  has	
  had	
  one	
  	
  
                            Fr	
  Vernon	
  Johnson	
  
•  1)	
  You	
  can	
  never	
  tell	
  how	
  much	
  of	
  the	
  
   chemical	
  it	
  will	
  take	
  to	
  put	
  you	
  into	
  the	
  
   blackout	
  again.	
  
•  2)	
  You	
  can	
  never	
  tell	
  how	
  long	
  the	
  blackout	
  
   will	
  last.	
  
•  3)	
  There	
  is	
  no	
  connec2on	
  between	
  our	
  value	
  
   system	
  and	
  what	
  we	
  will	
  do	
  in	
  a	
  blackout.	
  
Problems	
  seen:	
  
•  Slurred	
  speech	
  –	
  
   frequent	
  drunkenness	
  
•  Personal	
  problems	
  
•  Paren2ng	
  problems	
  
•  Sexual	
  dysfunc2on	
  or	
  
   promiscuity	
  
•  Insomnia	
  
•  Having	
  ONLY	
  friends	
  
   who	
  like	
  to	
  party	
  
Problems	
  con2nued:	
  
•  Frequent	
  promises	
  to	
  cut	
  back	
  
•  Avoiding	
  social	
  func2ons	
  unless	
  
   “altered”	
  
•  Memory	
  problems	
  
•  Mood	
  swings	
  
•  Blaming	
  of	
  behavior	
  on	
  others	
  
•  Withdrawal	
  into	
  isola2on	
  
Impairment	
  signs/symptoms	
  in	
  the	
  
                      workplace:	
  
•  Changes	
  in	
  the	
  manner	
  in	
  which	
  
   pa2ents	
  and	
  colleagues	
  are	
  treated	
  
•  Deteriora2on	
  of	
  personal	
  
   appearance	
  and	
  hygiene	
  
•  Loss	
  of	
  interest	
  in	
  work,	
  or….	
  
•  “Super	
  Pharmacist”	
  or	
  Super	
  
   whatever	
  
Workplace	
  con2nued:	
  
•  Poor	
  record	
  keeping	
  
•  Problems	
  with	
  concentra2on	
  
•  Med	
  errors	
  or	
  whatever	
  
•  Absenteeism	
  or	
  tardiness,	
  esp.	
  
   on	
  day	
  following	
  days	
  off	
  
•  Pa[ern	
  of	
  frequent	
  job	
  changes	
  
Workplace	
  con2nued:	
  

• Paranoia	
  
• Frequent	
  trips	
  to	
  the	
  
  bathroom	
  
• Mood	
  swings	
  
• Periods	
  of	
  unemployment	
  
Am	
  I	
  an	
  alcoholic?	
  
•  1.	
  	
  Have	
  you	
  ever	
  decided	
  to	
  stop	
  drinking	
  for	
  a	
  
   week	
  or	
  so,	
  but	
  only	
  lasted	
  for	
  a	
  couple	
  of	
  days?	
  
   2	
  -­‐	
  Do	
  you	
  wish	
  people	
  would	
  mind	
  their	
  own	
  
   business	
  about	
  your	
  drinking-­‐-­‐	
  stop	
  telling	
  you	
  
   what	
  to	
  do?	
  
   3	
  -­‐	
  Have	
  you	
  ever	
  switched	
  from	
  one	
  kind	
  of	
  
   drink	
  to	
  another	
  in	
  the	
  hope	
  that	
  this	
  would	
  
   keep	
  you	
  from	
  gesng	
  drunk?	
  
   4	
  -­‐	
  Have	
  you	
  had	
  to	
  have	
  an	
  eye-­‐opener	
  upon	
  
   awakening	
  during	
  the	
  past	
  year?	
  
Am	
  I	
  an	
  alcoholic?	
  
•  5	
  -­‐	
  Do	
  you	
  envy	
  people	
  who	
  can	
  drink	
  
   without	
  gesng	
  into	
  trouble?	
  
   6	
  -­‐	
  Have	
  you	
  had	
  problems	
  connected	
  with	
  
   drinking	
  during	
  the	
  past	
  year?	
  
   7	
  -­‐	
  Has	
  your	
  drinking	
  caused	
  trouble	
  at	
  
   home?	
  
   8	
  -­‐	
  Do	
  you	
  ever	
  try	
  to	
  get	
  "extra"	
  drinks	
  at	
  a	
  
   party	
  because	
  you	
  do	
  not	
  get	
  enough?	
  
Am	
  I	
  an	
  alcoholic?	
  
•  9	
  -­‐	
  Do	
  you	
  tell	
  yourself	
  you	
  can	
  stop	
  drinking	
  
   any	
  2me	
  you	
  want	
  to,	
  even	
  though	
  you	
  keep	
  
   gesng	
  drunk	
  when	
  you	
  don't	
  mean	
  to?	
  
   10	
  -­‐	
  Have	
  you	
  missed	
  days	
  of	
  work	
  or	
  school	
  
   because	
  of	
  drinking?	
  
   11	
  -­‐	
  Do	
  you	
  have	
  "blackouts"?	
  
   12	
  -­‐	
  Have	
  you	
  ever	
  felt	
  that	
  your	
  life	
  would	
  be	
  
   be[er	
  if	
  you	
  did	
  not	
  drink?	
  
p9	
  


                           CAGE-­‐AID	
  

    • Cut	
  down	
  
    • Annoyed	
  
    • Guilty	
  
    • Eye	
  opener	
  
CAGE-AID: CAGE Questions
Adapted to Include Other         JAMA 252:1905-1907, 1984
Drugs                            Am J Med 82:231-235, 1987
CAGE-­‐AID	
  
1.	
  Have	
  you	
  felt	
  you	
  ought	
  to	
  cut	
  down	
  on	
  your	
  drinking	
  
      or	
  drug	
  use?	
  
2.	
  Have	
  people	
  annoyed	
  you	
  by	
  cri=cizing	
  your	
  drinking	
  
      or	
  drug	
  use?	
  	
  
3.	
  Have	
  you	
  felt	
  bad	
  or	
  guilty	
  about	
  your	
  drinking	
  or	
  drug	
  
      use? 	
  	
  	
  
4.	
  Have	
  you	
  ever	
  had	
  a	
  drink	
  or	
  used	
  drugs	
  first	
  thing	
  in	
  
      the	
  morning	
  to	
  steady	
  your	
  nerves,	
  get	
  rid	
  of	
  a	
  
      hangover,	
  or	
  get	
  the	
  day	
  started?	
  	
  
   	
   	
  Screen	
  posi5ve	
  score	
  =	
  1+or	
  2+	
  

   	
   	
     	
     	
     	
  	
  
CRAFFT	
  Ques2ons	
  
5.  Have	
  you	
  ever	
  ridden	
  in	
  a	
  CAR	
  driven	
  by	
  someone	
  
     (including	
  yourself)	
  who	
  was	
  “high”	
  or	
  had	
  been	
  using	
  
     alcohol	
  or	
  drugs?	
  
6.  Do	
  you	
  ever	
  use	
  alcohol	
  or	
  drugs	
  to	
  RELAX,	
  feel	
  beder	
  
     about	
  yourself,	
  or	
  fit	
  in?	
  
7.  Do	
  you	
  ever	
  use	
  alcohol/drugs	
  while	
  you	
  are	
  by	
  yourself,	
  
     ALONE?	
  
8.  Do	
  your	
  family	
  or	
  FRIENDS	
  ever	
  tell	
  you	
  that	
  you	
  should	
  cut	
  
     down	
  on	
  your	
  drinking	
  or	
  drug	
  use?	
  
9.  Do	
  you	
  ever	
  FORGET	
  things	
  you	
  did	
  while	
  you	
  were	
  using	
  
     alcohol	
  or	
  drugs?	
  
10.  Have	
  you	
  goden	
  into	
  TROUBLE	
  while	
  you	
  were	
  using	
  	
  	
  	
  
     alcohol	
  or	
  drugs?	
  
     	
      	
  Screen	
  posi5ve	
  score	
  =	
  2+	
  
      	
     	
     	
  	
  
But	
  I	
  can’t	
  be	
  one!!!!!!!!!!	
  
If…then	
  three	
  courses	
  of	
  ac2on:	
  
•  Sober	
  up	
  
•  Get	
  locked	
  up	
  
•  Get	
  covered	
  
   up	
  =	
  PUAD	
  	
  
Do	
  they	
  have	
  to	
  reach	
  this	
  level?	
  
It	
  is	
  this	
  serious	
  folks!	
  
To	
  whom	
  do	
  I	
  turn	
  for	
  help?	
  
  Do	
  you	
  call	
  the	
  
   professional’s	
  licensing	
  
   Board?	
  
  Board	
  balances	
  
   regula2on	
  with	
  
   compassion	
  
  Is	
  it	
  a	
  bad	
  person	
  in	
  
   need	
  of	
  punishment	
  or	
  
   an	
  ill	
  person	
  in	
  need	
  of	
  
   care?	
  
There	
  is	
  an	
  op2on	
  in	
  some	
  states	
  
  You	
  could	
  call	
  your	
  
   state’s	
  recovery	
  
   program	
  
  I	
  publish	
  my	
  office/
   home	
  phone	
  number	
  
  The	
  website	
  
   www.usaprn.org	
  has	
  a	
  
   directory	
  of	
  state	
  
   programs	
  
Referral	
  by:	
  
•    Board	
  
•    Self	
  
•    Colleague	
  or	
  employer	
  
•    Family	
  
•    Interven2on	
  
•    ***anonymous	
  
Why	
  do	
  they	
  ask	
  for	
  help?	
  
• Liver	
  
• Lover	
  
• Livelihood	
  
• Law	
  
Then	
  what	
  happens?	
  
Evalua2on	
  
•  KYPRN	
  uses	
  addic2ons	
  
   psychiatrists	
  and	
  
   some2mes	
  a	
  residen2al	
  
   3-­‐5	
  day	
  assessment	
  
•  Results	
  of	
  evalua2ons	
  
   will	
  determine	
  to	
  a	
  large	
  
   extent	
  what	
  type	
  of	
  
   treatment.	
  	
  It	
  may	
  be	
  
   AA/NA,	
  IOP,	
  Long-­‐term	
  
   residen2al	
  or	
  other	
  or	
  a	
  
   combina2on	
  
Yes…Rehab	
  does	
  work!	
  
Goals	
  of	
  Addic2on	
  Therapy:	
  
•  Reduc2on	
  or	
  elimina2on	
  of	
  denial	
  
•  Increased	
  self	
  care	
  
•  Treatment	
  of	
  medical	
  and	
  psychiatric	
  
   problems	
  
•  Treatment	
  of	
  co-­‐morbid	
  family	
  
•  Educa2on	
  to	
  protect	
  himself	
  or	
  herself	
  from	
  
   substance	
  abuse	
  disease	
  
Contracts	
  
•  For	
  a	
  specific	
  length	
  of	
  2me	
  –	
  usually	
  5	
  
   yrs	
  
•  Shared	
  with	
  employer	
  –	
  if	
  per2nent	
  
•  May	
  limit	
  number	
  of	
  hours	
  worked	
  
•  Approved	
  prac2ce	
  site	
  or	
  type	
  
•  CAPTASA,	
  U	
  of	
  Utah,	
  SE	
  PRN	
  
Other	
  things	
  
•  Mee2ng	
  
   documenta2on	
  
   forms	
  
•  Medica2on	
  use	
  lists	
  
•  Monthly	
  self-­‐report	
  
   form	
  
•  Urine	
  Drug	
  Screens	
  
Pharmacist	
  may	
  have:	
  
•  Modifica2on	
  of	
  prac2ce	
  type	
  
•  Prac2ce	
  monitoring	
  by	
  peers/others	
  
•  Protocols	
  for	
  required	
  mood-­‐altering	
  drugs	
  
   for	
  a	
  legi2mate	
  medical	
  problem	
  
•  Consequences	
  should	
  she	
  return	
  to	
  substance	
  
   use	
  
Conclusion	
  
•  Substance	
  abuse	
  by	
  
   HCP	
  is	
  a	
  condi2on	
  that	
  
   has	
  become	
  
   increasingly	
  recognized	
  
   over	
  the	
  past	
  20+	
  
   years.	
  	
  We’ve	
  worked	
  
   hard	
  to	
  develop	
  
   treatment	
  protocols	
  
   and	
  support	
  programs.	
  
Treatment	
  does	
  work!	
  
  The	
  vast	
  majority	
  of	
  
   Pharmacists	
  who	
  
   successfully	
  complete	
  
   treatment	
  and	
  
   par2cipate	
  in	
  a{ercare	
  
   monitoring	
  CAN	
  and	
  
   DO	
  successfully	
  return	
  
   to	
  prac2ce.	
  
  HIRE	
  THE	
  RECOVERING	
  
   PROFESSIONAL	
  
“The	
  alcoholic	
  is	
  like	
  a	
  tornado	
  roaring	
  through	
  the	
  lives	
  of	
  
                                   others.”	
  page	
  82	
  
                            From	
  the	
  book:	
  “Alcoholics	
  Anonymous”	
  
Page	
  82	
  also	
  says:	
  “Hearts	
  are	
  broken.”	
  	
  Our	
  goal	
  is:	
  Recovery	
  
                                	
  From	
  the	
  book:	
  “Alcoholics	
  Anonymous”	
  


      Recovery:	
  by	
  
      Mike	
  Vye	
  
Not	
  this:	
  
True	
  or	
  False	
  
•  “Alcoholism,	
  chemical	
  addic2on,	
  is	
  a	
  disease,	
  
   the	
  very	
  nature	
  of	
  which	
  renders	
  the	
  vic2m	
  
   incapable	
  of	
  recognizing	
  the	
  severity	
  of	
  the	
  
   symptoms,	
  the	
  progression	
  of	
  the	
  disease,	
  or	
  
   of	
  accep2ng	
  any	
  ordinary	
  offers	
  of	
  help.”	
  
•  TRUE	
  
True	
  or	
  False	
  
•  In	
  a	
  diagnosis	
  of	
  addic2on	
  using	
  DSM	
  IV	
  
   criteria,	
  one	
  must	
  exhibit	
  any	
  2	
  out	
  of	
  7	
  
   of	
  the	
  criteria	
  within	
  the	
  past	
  6	
  months.	
  
•  FALSE	
  
True	
  or	
  False	
  
•  Gene2cs	
  is	
  the	
  sole	
  determining	
  factor	
  
   as	
  to	
  whether	
  someone	
  becomes	
  
   addicted	
  to	
  a	
  substance	
  or	
  process.	
  
•  FALSE	
  
True	
  or	
  False	
  
•  The	
  prognosis	
  for	
  someone	
  who	
  is	
  
   addicted	
  to	
  a	
  substance	
  includes	
  these	
  
   three:	
  1)	
  get	
  sober;	
  2)	
  get	
  locked	
  up;	
  or	
  
   3)	
  DIE	
  
•  TRUE	
  
Have	
  you	
  ever	
  wondered?	
  
Ques2ons?	
  
•  Brian	
  Fingerson,	
  RPh	
  
•  202	
  Bellemeade	
  Road	
  
•  Louisville,	
  KY	
  
   40222-­‐4502	
  
•  502-­‐749-­‐8385	
  
•  Email	
  =	
  kyprn@a[.net	
  	
  	
  
Thank	
  you	
  
                   Thank
                   you
                   Thank
                   you
                   Thank
                   you

Weitere ähnliche Inhalte

Was ist angesagt?

SOC 204 Goldberg Ch 2 & 3 F15 HYBRID
SOC 204 Goldberg Ch 2 & 3 F15 HYBRIDSOC 204 Goldberg Ch 2 & 3 F15 HYBRID
SOC 204 Goldberg Ch 2 & 3 F15 HYBRIDMichelle Meyer
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanOPUNITE
 
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...Dr. Glenda Clare (LION)
 
OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020StaceyConroy3
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesOPUNITE
 
Integrated treatmentforco occuringdisordersjaypiland
Integrated treatmentforco occuringdisordersjaypilandIntegrated treatmentforco occuringdisordersjaypiland
Integrated treatmentforco occuringdisordersjaypilandJay Piland MD, FASAM
 
Integrating Treatment for Co-Occurring Disorders
Integrating Treatment for Co-Occurring DisordersIntegrating Treatment for Co-Occurring Disorders
Integrating Treatment for Co-Occurring DisordersJay Piland MD, FASAM
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11ossmc
 
Assessment of substance use disorders 010915
Assessment of substance use disorders 010915Assessment of substance use disorders 010915
Assessment of substance use disorders 010915Tom Wilson
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
SOC 204 Goldberg Ch 2 3 & 4 Week 2
SOC 204 Goldberg Ch 2 3 & 4 Week 2SOC 204 Goldberg Ch 2 3 & 4 Week 2
SOC 204 Goldberg Ch 2 3 & 4 Week 2Michelle Cottrell
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gayOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 

Was ist angesagt? (20)

SOC 204 Goldberg Ch 2 & 3 F15 HYBRID
SOC 204 Goldberg Ch 2 & 3 F15 HYBRIDSOC 204 Goldberg Ch 2 & 3 F15 HYBRID
SOC 204 Goldberg Ch 2 & 3 F15 HYBRID
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...The Triple Challenge:Optimizing HIV Treatment for Patients with Co-occurring...
The Triple Challenge: Optimizing HIV Treatment for Patients with Co-occurring...
 
OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
 
Integrated treatmentforco occuringdisordersjaypiland
Integrated treatmentforco occuringdisordersjaypilandIntegrated treatmentforco occuringdisordersjaypiland
Integrated treatmentforco occuringdisordersjaypiland
 
Integrating Treatment for Co-Occurring Disorders
Integrating Treatment for Co-Occurring DisordersIntegrating Treatment for Co-Occurring Disorders
Integrating Treatment for Co-Occurring Disorders
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11
 
Chapter 2
Chapter 2Chapter 2
Chapter 2
 
Assessment of substance use disorders 010915
Assessment of substance use disorders 010915Assessment of substance use disorders 010915
Assessment of substance use disorders 010915
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
SOC 204 Goldberg Ch 2 3 & 4 Week 2
SOC 204 Goldberg Ch 2 3 & 4 Week 2SOC 204 Goldberg Ch 2 3 & 4 Week 2
SOC 204 Goldberg Ch 2 3 & 4 Week 2
 
Prevention
PreventionPrevention
Prevention
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gay
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 

Ähnlich wie Risk recognize resolve_addiction_in_the_pharmacy_profession

402 substance use lecture fall2011
402 substance use lecture fall2011402 substance use lecture fall2011
402 substance use lecture fall2011dceppos
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverOPUNITE
 
Substance abuse slides
Substance abuse slidesSubstance abuse slides
Substance abuse slidesMVNPA
 
Frances Harding
Frances HardingFrances Harding
Frances HardingOPUNITE
 
Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)brittneyleanngraves
 
Addictiondiseasemodel 100626143625-phpapp01
Addictiondiseasemodel 100626143625-phpapp01Addictiondiseasemodel 100626143625-phpapp01
Addictiondiseasemodel 100626143625-phpapp01ShandiLindsey
 
Substance abuse
Substance abuseSubstance abuse
Substance abuseGolden Eye
 
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdf
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdfLiberty Study Guide and Answers Homeworksimple.com_Part3.pdf
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdfHomework Simple
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Drug awareness Slides for Houghton House addiction rehabilitation
Drug awareness Slides for Houghton House addiction rehabilitation Drug awareness Slides for Houghton House addiction rehabilitation
Drug awareness Slides for Houghton House addiction rehabilitation DyWilliams1
 
Substance Abuse in Older Adults
Substance Abuse in Older AdultsSubstance Abuse in Older Adults
Substance Abuse in Older AdultsBrookdale
 
Action research on drug safety assestment
Action research on drug safety assestmentAction research on drug safety assestment
Action research on drug safety assestmentReymart Bargamento
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaLeadingAge
 
Dfsp 1hr. emp refresher 2016 revised
Dfsp   1hr. emp refresher 2016 revisedDfsp   1hr. emp refresher 2016 revised
Dfsp 1hr. emp refresher 2016 revisedBeyond Marketing
 
Closing the treatment gap in alcohol dependence thessalonika 2015
Closing the treatment gap in alcohol dependence thessalonika 2015Closing the treatment gap in alcohol dependence thessalonika 2015
Closing the treatment gap in alcohol dependence thessalonika 2015Antoni Gual
 

Ähnlich wie Risk recognize resolve_addiction_in_the_pharmacy_profession (20)

402 substance use lecture fall2011
402 substance use lecture fall2011402 substance use lecture fall2011
402 substance use lecture fall2011
 
Abuse/Dependece/Addiction
Abuse/Dependece/AddictionAbuse/Dependece/Addiction
Abuse/Dependece/Addiction
 
Dual Diagnosis
Dual DiagnosisDual Diagnosis
Dual Diagnosis
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
 
Substance abuse slides
Substance abuse slidesSubstance abuse slides
Substance abuse slides
 
Relapse Recovery in Pharmacists
Relapse Recovery in PharmacistsRelapse Recovery in Pharmacists
Relapse Recovery in Pharmacists
 
Frances Harding
Frances HardingFrances Harding
Frances Harding
 
Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)Week 1-sbirt-attc-workwise-series (1)
Week 1-sbirt-attc-workwise-series (1)
 
Addictiondiseasemodel 100626143625-phpapp01
Addictiondiseasemodel 100626143625-phpapp01Addictiondiseasemodel 100626143625-phpapp01
Addictiondiseasemodel 100626143625-phpapp01
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
 
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdf
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdfLiberty Study Guide and Answers Homeworksimple.com_Part3.pdf
Liberty Study Guide and Answers Homeworksimple.com_Part3.pdf
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Addiction Counselor Certification Training Series: Models and theories of men...
Addiction Counselor Certification Training Series: Models and theories of men...Addiction Counselor Certification Training Series: Models and theories of men...
Addiction Counselor Certification Training Series: Models and theories of men...
 
Drug awareness Slides for Houghton House addiction rehabilitation
Drug awareness Slides for Houghton House addiction rehabilitation Drug awareness Slides for Houghton House addiction rehabilitation
Drug awareness Slides for Houghton House addiction rehabilitation
 
Shanahan intro sbirt basics ss
Shanahan intro  sbirt basics ssShanahan intro  sbirt basics ss
Shanahan intro sbirt basics ss
 
Substance Abuse in Older Adults
Substance Abuse in Older AdultsSubstance Abuse in Older Adults
Substance Abuse in Older Adults
 
Action research on drug safety assestment
Action research on drug safety assestmentAction research on drug safety assestment
Action research on drug safety assestment
 
Reducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for DementiaReducing Antipsychotic Drug Use for Dementia
Reducing Antipsychotic Drug Use for Dementia
 
Dfsp 1hr. emp refresher 2016 revised
Dfsp   1hr. emp refresher 2016 revisedDfsp   1hr. emp refresher 2016 revised
Dfsp 1hr. emp refresher 2016 revised
 
Closing the treatment gap in alcohol dependence thessalonika 2015
Closing the treatment gap in alcohol dependence thessalonika 2015Closing the treatment gap in alcohol dependence thessalonika 2015
Closing the treatment gap in alcohol dependence thessalonika 2015
 

Mehr von OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200OPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenOPUNITE
 

Mehr von OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 

Risk recognize resolve_addiction_in_the_pharmacy_profession

  • 1. Risk,  Recognize,  Resolve:  Addic2on   in  the   Pharmacy  Profession     April  2  –  4,  2013   Omni  Orlando  Resort     at  ChampionsGate  
  • 2. Learning  Objec2ves   •  1.  Iden=fy  risk  factors  for  pharmacy  professionals  that   may  influence  the  development  of  the  disease  of   addic=on.   •  2.  Iden=fy  the  signs  and  symptoms  of  the  disease  of   addic=on.   •  3.  Describe  the  resources  available  to  pharmacy   professionals  when  a  colleague  may  need  assistance   with  addic=on  or  substance  abuse  issues.   •  4.  Describe  the  structure  of  accountability  added  to  the   recovery  person  by  monitoring  with  a  Pharmacist   Recovery  Network.  
  • 3. Disclosure  Statement   Brian  Fingerson  has  no  financial  rela=onships   with  proprietary  en==es  that  produce  health   care  goods  and  services.  
  • 4. Brian  Fingerson,  RPh   •  President,  KYPRN  –  Kentucky  Professionals  Recovery   Network  since  1986   •  Clients/professions  include:  Accountants,  Pharmacy,   Den=stry,  Physical  Therapy,  Veterinary  Medicine,   Respiratory  Care,  Optometry,  Chiroprac=c,  Social   Work   •  Work  with  these  professionals  through  their  licensing   Boards  
  • 5. What  do  you  know?   Self-­‐Assessment  Ques2ons  T  or  F   •  In  a  diagnosis  of  addic=on  using  DSM  IV  criteria,  one  must  exhibit  any   two  out  of  seven  of  the  criteria  within  the  past  six  months.     •  Gene=cs  is  the  sole  determining  factor  as  to  whether  someone  becomes   addicted  to  a  substance  or  process.   •  The  prognosis  for  someone  who  is  addicted  to  a  substance  includes  these   three:  1)  get  sober;  2)  get  locked  up;  or  3)  die.   •  Alcoholism,  chemical  addic=on,  is  a  disease,  the  very  nature  of  which   renders  the  vic=m  incapable  of  recognizing  the  severity  of  the  symptoms,   the  progression  of  the  disease,  or  of  accep=ng  any  ordinary  offers  of   help.  
  • 6. And  why  should  we  learn  about  addic2on  in   pharmacy  professionals?   Crit  Care  Med.  2007  Feb;35(2  Suppl):S106-­‐16   Baldisseri  MR.   Cri=cal  Care  Medicine,  University  of  Pidsburgh  School   of  Medicine,  Pidsburgh,  Pennsylvania,  USA.     OBJECTIVE:  The  objec1ve  of  the  ar1cle  is  to  present  the   available  data  from  the  literature  on  substance  use   disorders  in  healthcare  professionals.  Prevalence,  risk   factors,  treatment  op1ons,  and  reentry  into  clinical   prac1ce  are  discussed.  
  • 7. Crit  Care  Med.  2007  Feb;35(2  Suppl):S106-­‐16   Baldisseri  MR.   •  INTRODUCTION:  Impairment  of  a  healthcare  professional  is   the  inability  or  impending  inability  to  prac5ce  according  to   accepted  standards  as  a  result  of  substance  use,  abuse,  or   dependency  (addic5on).  The  term  substance  use  disorder  can   be  divided  into  substance  abuse  and  dependence  (addic1on).   Substance  abuse  results  in  adverse  social  and  professional   consequences.  Addic5on  manifests  as  physiologic  and   behavioral  symptoms  related  to  a  maladap1ve  paLern  of   substance  use.   •  MAIN  RESULTS:  It  is  es1mated  that  approximately  10%  to   15%  of  all  healthcare  professionals  will  misuse  drugs  or   alcohol  alcohol  some  1me  during  their  career.  
  • 8. Why  do  people  take   drugs  “recrea2onally”  in   the  first  place?  
  • 9. People  Take  Drugs  To:   • Feel  good  (sensa2on  seeking)   • Feel  be[er  (self-­‐medica2on)  
  • 10. A  major  reason  people  take     a  psychoac2ve  drug  is  they   like  what   it  does  to  their  brains  
  • 11. Prolonged drug use changes the brain in fundamental and long-lasting ways
  • 12. Reward Pathway Frontal  Cortex   Wow!!!   Addiction is a Opiates brain disease Alcohol Cocaine Amphetamines Marijuana
  • 13. Young adults  may   be less           likely to develop serious alcohol and other drug problems if the age of first use is delayed beyond childhood or adolescence
  • 14. AA  Grapevine  e-­‐poll   Ques2on:  At  what  age  did   you  have  your  first  drink?     Total  Responded:  7947     0-­‐11   2308  votes  (29.04  %)   12-­‐18   5110  votes  (64.3  %)   19-­‐26   420  votes  (5.29  %)   27-­‐40   52  votes  (0.65  %)   41  or  older   57  votes  (0.72  %)  
  • 15. Addic2on:  One  Defini2on   •  A  primary,  chronic,  neurobiological  disease,   with  gene2c,  psychosocial,  and   environmental  factors  influencing  its   development  and  manifesta2ons.    It  is   characterized  by  behaviors  that  include  one   or  more  of  the  following:  
  • 16. Addic2on  behaviors:   •  Impaired  control   over  drug  use   •  Compulsive  use   •  Con2nued  use   despite  harm   •  Craving  
  • 17. Fr  Vernon  Johnson’s  defini2on  of  addic2on   •  “”Alcoholism,  chemical  addic2on,  is  a   disease,  the  very  nature  of  which  renders  the   vic2m  incapable  of  recognizing  the  severity   of  the  symptoms,  the  progression  of  the   disease,  or  of  accep2ng  any  ordinary  offers  of   help.”  
  • 18. DSM  IV:  Diagnosis  of  Addic2on   (3  out  of  7  in  past  12  months)   1.  Tolerance   2.  Withdrawal   Loss  of  Control:   3.  Used  more  and  longer  than  planned   4.  Unsuccessful  a[empts  to  quit  or  control  use   5.  Excessive  2me  spent  obtaining,  using,  or         recovering  from  use   6.  Important  ac2vi2es  given  up   7.  Con2nued  use  despite  adverse  consequences  
  • 20. Risk  as  a  healthcare  professional?    Don’t  know  of   anyone  yet  whose   reason  for   becoming  a   pharmacist  was   drug  access.    But… maybe  so?  
  • 21. Risk  Factors   •  General  Public  =  10%   •  Pharmacists  and  some  other   health  care  professionals  =  HCP  =   12-­‐16%  
  • 22. So…Why  an  increased  risk  factor?   •  Access  to  drugs   •  Stress   •  Knowledge   •  Family  history  =  1   parent  20-­‐25%   chance,  2  parents   30-­‐50%  
  • 23.  And  how  can  this  be,  you  say?   •  Dean  Dabney  in   JAPhA,  May/June   2001   •  Vol.  41,  No.  3     •  Use  of  Mind  Altering   or  Poten2ally   Addic2ve  Prescrip2on   Drugs  (PAPD)  
  • 24. Who  was  asked?   •  It  was  a  random  sample  of   licensed,  prac2cing  pharmacists   who  were  members  of  APhA  in   the  fall  of  1996.  
  • 25.    And  what  did  the  study      show?   •  40%  indicated  using  PAPD   without  1st  obtaining  an   Rx   •  20%  reported  5  or  more   life2me  episodes   •  6%  reported  10  or  more   life2me  episodes   •  6%  iden2fying  as  being   drug  abusers   •  Drugs  obtained  by   stealing  drugs  from   employers  or  forging  Rx  
  • 26. DENIAL – not just a river in Egypt* Yes – it has been said before! •  Don’t   •  Even   •  Know   •  I   •  Am   •  Lying  
  • 27. Denial   from  Knots  by  R.D.  Lang   •  There  must  be  something  the   ma[er  with  him  because  he  would   not  be  ac2ng  as  he  does  unless   there  was.    Therefore  he  is  ac2ng  as   he  is  because  there  is  something  the   ma[er  with  him.  
  • 28. Denial  con2nued:   •  He  does  not  think  there  is  anything  the   ma[er  with  him  because  one  of  the  things   that  is  the  ma[er  with  him  is  that  he  does   not  think  that  there  is  anything  the  ma[er   with  him.   •  Therefore  we  have  to  help  him  realize  that,   the  fact  that  he  does  not  think  there  is   anything  the  ma[er  with  him  is  one  of  the   things  that  is  the  ma[er  with  him.  
  • 29. HCP  good  at  “cover  up”  and  if   confronted  will  deny   •  Denial  is  not  just  a  river  in  Egypt   •  Paranoia  and  irritability   •  Depression   •  Use  of  large  quan22es  of  alcohol  –  more   than  normal  or  more  than  others   present   •  Blackouts  
  • 30. Blackouts   -­‐  Once  a  person  has  had  one     Fr  Vernon  Johnson   •  1)  You  can  never  tell  how  much  of  the   chemical  it  will  take  to  put  you  into  the   blackout  again.   •  2)  You  can  never  tell  how  long  the  blackout   will  last.   •  3)  There  is  no  connec2on  between  our  value   system  and  what  we  will  do  in  a  blackout.  
  • 31. Problems  seen:   •  Slurred  speech  –   frequent  drunkenness   •  Personal  problems   •  Paren2ng  problems   •  Sexual  dysfunc2on  or   promiscuity   •  Insomnia   •  Having  ONLY  friends   who  like  to  party  
  • 32. Problems  con2nued:   •  Frequent  promises  to  cut  back   •  Avoiding  social  func2ons  unless   “altered”   •  Memory  problems   •  Mood  swings   •  Blaming  of  behavior  on  others   •  Withdrawal  into  isola2on  
  • 33. Impairment  signs/symptoms  in  the   workplace:   •  Changes  in  the  manner  in  which   pa2ents  and  colleagues  are  treated   •  Deteriora2on  of  personal   appearance  and  hygiene   •  Loss  of  interest  in  work,  or….   •  “Super  Pharmacist”  or  Super   whatever  
  • 34. Workplace  con2nued:   •  Poor  record  keeping   •  Problems  with  concentra2on   •  Med  errors  or  whatever   •  Absenteeism  or  tardiness,  esp.   on  day  following  days  off   •  Pa[ern  of  frequent  job  changes  
  • 35. Workplace  con2nued:   • Paranoia   • Frequent  trips  to  the   bathroom   • Mood  swings   • Periods  of  unemployment  
  • 36. Am  I  an  alcoholic?   •  1.    Have  you  ever  decided  to  stop  drinking  for  a   week  or  so,  but  only  lasted  for  a  couple  of  days?   2  -­‐  Do  you  wish  people  would  mind  their  own   business  about  your  drinking-­‐-­‐  stop  telling  you   what  to  do?   3  -­‐  Have  you  ever  switched  from  one  kind  of   drink  to  another  in  the  hope  that  this  would   keep  you  from  gesng  drunk?   4  -­‐  Have  you  had  to  have  an  eye-­‐opener  upon   awakening  during  the  past  year?  
  • 37. Am  I  an  alcoholic?   •  5  -­‐  Do  you  envy  people  who  can  drink   without  gesng  into  trouble?   6  -­‐  Have  you  had  problems  connected  with   drinking  during  the  past  year?   7  -­‐  Has  your  drinking  caused  trouble  at   home?   8  -­‐  Do  you  ever  try  to  get  "extra"  drinks  at  a   party  because  you  do  not  get  enough?  
  • 38. Am  I  an  alcoholic?   •  9  -­‐  Do  you  tell  yourself  you  can  stop  drinking   any  2me  you  want  to,  even  though  you  keep   gesng  drunk  when  you  don't  mean  to?   10  -­‐  Have  you  missed  days  of  work  or  school   because  of  drinking?   11  -­‐  Do  you  have  "blackouts"?   12  -­‐  Have  you  ever  felt  that  your  life  would  be   be[er  if  you  did  not  drink?  
  • 39. p9   CAGE-­‐AID   • Cut  down   • Annoyed   • Guilty   • Eye  opener   CAGE-AID: CAGE Questions Adapted to Include Other JAMA 252:1905-1907, 1984 Drugs Am J Med 82:231-235, 1987
  • 40. CAGE-­‐AID   1.  Have  you  felt  you  ought  to  cut  down  on  your  drinking   or  drug  use?   2.  Have  people  annoyed  you  by  cri=cizing  your  drinking   or  drug  use?     3.  Have  you  felt  bad  or  guilty  about  your  drinking  or  drug   use?       4.  Have  you  ever  had  a  drink  or  used  drugs  first  thing  in   the  morning  to  steady  your  nerves,  get  rid  of  a   hangover,  or  get  the  day  started?        Screen  posi5ve  score  =  1+or  2+              
  • 41. CRAFFT  Ques2ons   5.  Have  you  ever  ridden  in  a  CAR  driven  by  someone   (including  yourself)  who  was  “high”  or  had  been  using   alcohol  or  drugs?   6.  Do  you  ever  use  alcohol  or  drugs  to  RELAX,  feel  beder   about  yourself,  or  fit  in?   7.  Do  you  ever  use  alcohol/drugs  while  you  are  by  yourself,   ALONE?   8.  Do  your  family  or  FRIENDS  ever  tell  you  that  you  should  cut   down  on  your  drinking  or  drug  use?   9.  Do  you  ever  FORGET  things  you  did  while  you  were  using   alcohol  or  drugs?   10.  Have  you  goden  into  TROUBLE  while  you  were  using         alcohol  or  drugs?      Screen  posi5ve  score  =  2+          
  • 42. But  I  can’t  be  one!!!!!!!!!!  
  • 43. If…then  three  courses  of  ac2on:   •  Sober  up   •  Get  locked  up   •  Get  covered   up  =  PUAD    
  • 44. Do  they  have  to  reach  this  level?  
  • 45. It  is  this  serious  folks!  
  • 46. To  whom  do  I  turn  for  help?     Do  you  call  the   professional’s  licensing   Board?     Board  balances   regula2on  with   compassion     Is  it  a  bad  person  in   need  of  punishment  or   an  ill  person  in  need  of   care?  
  • 47. There  is  an  op2on  in  some  states     You  could  call  your   state’s  recovery   program     I  publish  my  office/ home  phone  number     The  website   www.usaprn.org  has  a   directory  of  state   programs  
  • 48. Referral  by:   •  Board   •  Self   •  Colleague  or  employer   •  Family   •  Interven2on   •  ***anonymous  
  • 49. Why  do  they  ask  for  help?   • Liver   • Lover   • Livelihood   • Law  
  • 51. Evalua2on   •  KYPRN  uses  addic2ons   psychiatrists  and   some2mes  a  residen2al   3-­‐5  day  assessment   •  Results  of  evalua2ons   will  determine  to  a  large   extent  what  type  of   treatment.    It  may  be   AA/NA,  IOP,  Long-­‐term   residen2al  or  other  or  a   combina2on  
  • 53. Goals  of  Addic2on  Therapy:   •  Reduc2on  or  elimina2on  of  denial   •  Increased  self  care   •  Treatment  of  medical  and  psychiatric   problems   •  Treatment  of  co-­‐morbid  family   •  Educa2on  to  protect  himself  or  herself  from   substance  abuse  disease  
  • 54. Contracts   •  For  a  specific  length  of  2me  –  usually  5   yrs   •  Shared  with  employer  –  if  per2nent   •  May  limit  number  of  hours  worked   •  Approved  prac2ce  site  or  type   •  CAPTASA,  U  of  Utah,  SE  PRN  
  • 55. Other  things   •  Mee2ng   documenta2on   forms   •  Medica2on  use  lists   •  Monthly  self-­‐report   form   •  Urine  Drug  Screens  
  • 56. Pharmacist  may  have:   •  Modifica2on  of  prac2ce  type   •  Prac2ce  monitoring  by  peers/others   •  Protocols  for  required  mood-­‐altering  drugs   for  a  legi2mate  medical  problem   •  Consequences  should  she  return  to  substance   use  
  • 57. Conclusion   •  Substance  abuse  by   HCP  is  a  condi2on  that   has  become   increasingly  recognized   over  the  past  20+   years.    We’ve  worked   hard  to  develop   treatment  protocols   and  support  programs.  
  • 58. Treatment  does  work!     The  vast  majority  of   Pharmacists  who   successfully  complete   treatment  and   par2cipate  in  a{ercare   monitoring  CAN  and   DO  successfully  return   to  prac2ce.     HIRE  THE  RECOVERING   PROFESSIONAL  
  • 59. “The  alcoholic  is  like  a  tornado  roaring  through  the  lives  of   others.”  page  82   From  the  book:  “Alcoholics  Anonymous”  
  • 60. Page  82  also  says:  “Hearts  are  broken.”    Our  goal  is:  Recovery    From  the  book:  “Alcoholics  Anonymous”   Recovery:  by   Mike  Vye  
  • 62. True  or  False   •  “Alcoholism,  chemical  addic2on,  is  a  disease,   the  very  nature  of  which  renders  the  vic2m   incapable  of  recognizing  the  severity  of  the   symptoms,  the  progression  of  the  disease,  or   of  accep2ng  any  ordinary  offers  of  help.”   •  TRUE  
  • 63. True  or  False   •  In  a  diagnosis  of  addic2on  using  DSM  IV   criteria,  one  must  exhibit  any  2  out  of  7   of  the  criteria  within  the  past  6  months.   •  FALSE  
  • 64. True  or  False   •  Gene2cs  is  the  sole  determining  factor   as  to  whether  someone  becomes   addicted  to  a  substance  or  process.   •  FALSE  
  • 65. True  or  False   •  The  prognosis  for  someone  who  is   addicted  to  a  substance  includes  these   three:  1)  get  sober;  2)  get  locked  up;  or   3)  DIE   •  TRUE  
  • 66. Have  you  ever  wondered?  
  • 67. Ques2ons?   •  Brian  Fingerson,  RPh   •  202  Bellemeade  Road   •  Louisville,  KY   40222-­‐4502   •  502-­‐749-­‐8385   •  Email  =  kyprn@a[.net      
  • 68. Thank  you   Thank you Thank you Thank you